Abstract
Crispene E, a new clerodane-type diterpene, inhibited STAT3 dimerization in a cell-free fluorescent polarisation assay and was found to have significant toxicity against STAT3-dependent MDA-MB 231 breast cancer cell line and selectively inhibited the expression of STAT3 and STAT3 target genes cyclin D1, Fascin and bcl-2. Molecular docking studies suggest the molecule inhibits STAT3 by interacting with its SH2 domain. The compound has been isolated from Tinospora crispa and characterized using standard spectroscopic techniques.
Original language | English |
---|---|
Pages (from-to) | 3882-3886 |
Number of pages | 5 |
Journal | ORGANIC AND BIOMOLECULAR CHEMISTRY |
Volume | 13 |
Issue number | 13 |
DOIs | |
Publication status | Published - 7 Apr 2015 |